| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2004 | CN1502613A Polymorph of a pharmaceutical and prepation |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502608A Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
| 06/09/2004 | CN1502370A Composition for cooperative therapy and method thereof |
| 06/09/2004 | CN1502337A Oral medicine for treating cardio-cerebral vascular disease and preparation process thereof |
| 06/09/2004 | CN1502336A Application of Astragalosides in preparation of medicine for treating viral myocarditis |
| 06/09/2004 | CN1502335A Application of Netilmicin sulfate in preparation of eye drops |
| 06/09/2004 | CN1502334A Medicinal composition containing Adefovirdipivoxil |
| 06/09/2004 | CN1502333A Slow released table of captopril |
| 06/09/2004 | CN1502332A Process for preparing taxol self-emulsified solid nano granule-injection taxol of anti-cancer medicine |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1502330A Deodorizing products for oral cavity |
| 06/09/2004 | CN1502329A Deodorizing products for oral cavity |
| 06/09/2004 | CN1502325A Ascorbic acid aqueous solution and preparation process thereof |
| 06/09/2004 | CN1502263A Cancer chemoprotective food products |
| 06/09/2004 | CN1152886C Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/09/2004 | CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use |
| 06/09/2004 | CN1152880C Process for preparation of oxymorphone, oxycodone and derivatives |
| 06/09/2004 | CN1152878C Thiazolidinedione derivative and use as antidiabetic |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives |
| 06/09/2004 | CN1152873C Novel diphenyl-piperidine derivate |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152870C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152866C Benzimidazoles, production thereof and use thereof medicaments |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152861C N-substituted indolines as estrogenic agents |
| 06/09/2004 | CN1152857C Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 06/09/2004 | CN1152718C Stable oxaliplatin solution preparation and preparation process thereof |
| 06/09/2004 | CN1152717C Oral medicinal preparation |
| 06/09/2004 | CN1152716C Farnesyl protein transferase inhbitors with internal radiosensitizing |
| 06/09/2004 | CN1152700C Capsule for treating nervous headache an dpreparation process thereof |
| 06/09/2004 | CN1152693C Adhesion inhibiting composition |
| 06/09/2004 | CN1152690C Composite Triamcinolone Acetonide medicine for treating germ-free inflammation |
| 06/09/2004 | CN1152689C Activated vitamin D3 emulsion-type lotions |
| 06/09/2004 | CN1152688C usage of glucocorticoid in preparation medicine for treating glomerulonephritis and use for treating IgA nephrosis by said medicine |
| 06/09/2004 | CN1152687C Crystalline trimetrexate salts and the process for making the same |
| 06/09/2004 | CN1152686C Stable drug composition |
| 06/09/2004 | CN1152685C Usage of endothelin receptor agonist in preparation of medicine for treating obesity |
| 06/09/2004 | CN1152683C Medicinal composition containing naphthyl compound |
| 06/09/2004 | CN1152682C Usage of histamine receptor antagonists composition in preparation of medicine for treating |
| 06/09/2004 | CN1152681C 8a-azalides as veterinary antimicrobial agents for animals |
| 06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
| 06/09/2004 | CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent |
| 06/09/2004 | CN1152678C Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 06/09/2004 | CN1152677C Treatment of spasticity, convulsions by isovaleric acid derivatives CNS |
| 06/09/2004 | CN1152676C Combination preparation for treating malaria |
| 06/09/2004 | CN1152675C IL-8 receptor antagonists |
| 06/09/2004 | CN1152674C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/09/2004 | CN1152671C Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 06/09/2004 | CN1152669C Medicinal aerosol preparation, its preparing method and release device |
| 06/09/2004 | CA2452467A1 Novel methods for the treatment and prevention of pancreatitis and for induction of liver regeneration |
| 06/09/2004 | CA2413720A1 Novel methods for the treatment and prevention of pancreatitis and for induction of liver regeration |
| 06/08/2004 | US6747177 Process for the preparation of meso-zeaxanthin |
| 06/08/2004 | US6747158 Anticoagulants |
| 06/08/2004 | US6747154 Process for preparing scopine esters |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747149 Glucamine salts for treating hepatitis virus infections |
| 06/08/2004 | US6747144 Collections of compounds |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747064 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 06/08/2004 | US6747063 Augmenting actions of camp in an effector system while reducing camp action in a nociceptive system comprising application of one or more forms of nitrogen oxide or carbon monoxide to a site wherein camp exists |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747059 Composition for, and methods of, anti-platelet therapy |
| 06/08/2004 | US6747058 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747052 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/08/2004 | US6747050 Isoxazoline derivative and a process for the preparation thereof |
| 06/08/2004 | US6747049 Oxazole derivatives |
| 06/08/2004 | US6747045 Such as 1-(3-(((3,4-dihydro-2h-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1h)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747037 Treating ocular hypertension or glaucoma; reduced side effects |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747034 CRF receptor antagonists and methods relating thereto |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747030 Cis-6-(3,5-dimethylpiperazin-1-yl)-5-methoxy-1-(2'-methyl-4'-( 5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl)indoline, its hydrochloride salt, or another pharmaceutically acceptable salt thereof; antidepressants |
| 06/08/2004 | US6747029 Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder |
| 06/08/2004 | US6747028 1,2-substituted benzimidazoles having antiviral activity |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747020 Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor |
| 06/08/2004 | US6747019 Mixture of estrogen, progesterone; alternating dosage |
| 06/08/2004 | US6747017 Endopeptidase inhibitor |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/08/2004 | US6747015 Low molecular weight polymannuronate |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6747011 Treatment of lymphoma or breast cancer |
| 06/08/2004 | US6747010 NKT cell-activating agents containing α-glycosylceramides |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746861 Human kinase protein and polynucleotides encoding the same |